← back to search

Christopher C. Nixon

University of California, San Francisco · US
Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, and HIV/AIDS Research and Interventions.
h-index
16
citations
1,726
works
28
NIH funding
primary concept
email

Recent publications

First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
Nature Communications 2022cited by 48position: middledoi
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Cell Reports 2021cited by 264position: middledoi
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
Cells 2021cited by 187position: middledoi
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Science Advances 2021cited by 150position: middledoi
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Nature 2020cited by 317position: firstdoi
Essential Role of Human T Cell Leukemia Virus Type 1 <i>orf-I</i> in Lethal Proliferation of CD4 <sup>+</sup> Cells in Humanized Mice
Journal of Virology 2019cited by 19position: middledoi
In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies
The Journal of Infectious Diseases 2017cited by 39position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sadie E. Munter · University of California San Diego1 papers (2021–2021)Bing Sun · Stanford University1 papers (2021–2021)J. Daniel Kelly · San Francisco VA Medical Center1 papers (2021–2021)Timothy J. Henrich · World Wide Web Consortium1 papers (2021–2021)Jeffrey N. Martin · Global Solutions for Infectious Diseases1 papers (2021–2021)Dai Fujikawa · Center for Cancer Research1 papers (2019–2019)Guido Silvestri · International AIDS Vaccine Initiative1 papers (2017–2017) · 1 papers (2019–2019)Joanna Donatelli · Gilead Sciences (United States)1 papers (2021–2021)Cynthia A. Pise-Masison · National Institutes of Health1 papers (2019–2019) · 1 papers (2019–2019)Laura Romero · University of Miami1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)Veronica Galli · Center for Cancer Research1 papers (2019–2019)Maud Mavigner · Emory University1 papers (2017–2017)Michael J. Peluso · Cardiff University1 papers (2021–2021)J. Víctor García · University of North Carolina at Chapel Hill1 papers (2017–2017)Isabel Rodríguez-Barraquer · Global Solutions for Infectious Diseases1 papers (2021–2021)Breanna Caruso · National Institute of Neurological Disorders and Stroke1 papers (2019–2019)